40 related articles for article (PubMed ID: 6677978)
1. Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy.
Lidonnici D; Brambilla P; Ravasio R; Zozulya-Weidenfeller A; Beiderbeck A; van Aswegen M; Oliveira R; Sansone VA
J Neuromuscul Dis; 2024; 11(2):411-423. PubMed ID: 38306059
[TBL] [Abstract][Full Text] [Related]
2. Autosomal Recessive Myotonia Congenita in an Adolescent Boy With Novel Mutation: A Case Report With Discussion on Management.
Das P; Panigrahi D
Cureus; 2024 Feb; 16(2):e53981. PubMed ID: 38469025
[TBL] [Abstract][Full Text] [Related]
3. Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2.
Mousele C; Matthews E; Pitceathly RDS; Hanna MG; MacDonald S; Savvatis K; Carr A; Turner C
Neurol Clin Pract; 2021 Oct; 11(5):e682-e685. PubMed ID: 34840883
[TBL] [Abstract][Full Text] [Related]
4. Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel.
Chapman AM; Schurer M; Weijers L; Omar A; Lee H; Weidenfeller AZ; Ellis C; Sonecha S; Schneider-Gold C
BMC Neurol; 2021 Dec; 21(1):467. PubMed ID: 34852780
[TBL] [Abstract][Full Text] [Related]
5. Drug Repurposing for Rare Diseases: A Role for Academia.
van den Berg S; de Visser S; Leufkens HGM; Hollak CEM
Front Pharmacol; 2021; 12():746987. PubMed ID: 34744726
[No Abstract] [Full Text] [Related]
6. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
[TBL] [Abstract][Full Text] [Related]
7. Ventricular ectopy during REM sleep: implications for nocturnal sudden cardiac death.
Garcia-Touchard A; Somers VK; Kara T; Nykodym J; Shamsuzzaman A; Lanfranchi P; Ackerman MJ
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):284-8. PubMed ID: 17457352
[TBL] [Abstract][Full Text] [Related]
8. Drug treatment for myotonia.
Trip J; Drost G; van Engelen BG; Faber CG
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004762. PubMed ID: 16437496
[TBL] [Abstract][Full Text] [Related]
9. Repetitive nerve stimulation in the differential diagnosis of congenital myotonia.
Rossi B; Rossi A; Sartucci F
Ital J Neurol Sci; 1984 Dec; 5(4):385-90. PubMed ID: 6530361
[TBL] [Abstract][Full Text] [Related]
10. [Value of mexiletine in the treatment of Thomsen-Becker myotonia].
Leheup B; Himon F; Morali A; Brichet F; Vidailhet M
Arch Fr Pediatr; 1986 Jan; 43(1):49-50. PubMed ID: 3707279
[TBL] [Abstract][Full Text] [Related]
11. Myotonia congenita.
Gutmann L; Phillips LH
Semin Neurol; 1991 Sep; 11(3):244-8. PubMed ID: 1947487
[TBL] [Abstract][Full Text] [Related]
12. [Myotonia congenital (Thomsen) and recessive generalized myotonia (Becker)].
Kuhn E
Nervenarzt; 1993 Dec; 64(12):766-9. PubMed ID: 8114977
[TBL] [Abstract][Full Text] [Related]
13. [Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
Pouget J; Serratrice G
Rev Neurol (Paris); 1983; 139(11):665-72. PubMed ID: 6677978
[TBL] [Abstract][Full Text] [Related]
14. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy.
Jackson CE; Barohn RJ; Ptacek LJ
Muscle Nerve; 1994 Jul; 17(7):763-8. PubMed ID: 8008003
[TBL] [Abstract][Full Text] [Related]
15. Myotonia congenita--a cause of muscle weakness and stiffness.
Chrestian N; Puymirat J; Bouchard JP; Dupré N
Nat Clin Pract Neurol; 2006 Jul; 2(7):393-9; quiz following 399. PubMed ID: 16932590
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
